D.B. Root & Company, LLC Astrazeneca PLC Transaction History
D.B. Root & Company, LLC
- $320 Million
- Q2 2025
A detailed history of D.B. Root & Company, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, D.B. Root & Company, LLC holds 4,301 shares of AZN stock, worth $324,037. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,301
Previous 9,055
52.5%
Holding current value
$324,037
Previous $665,000
54.89%
% of portfolio
0.09%
Previous 0.22%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...